Skip to main content
. 2018 Apr 6;8(5):e00962. doi: 10.1002/brb3.962

Figure 2.

Figure 2

Change in driving ability in patients with MS spasticity treated with THC:CBD and who were able to drive when included onto an observational product registry in Germany, Switzerland, and the UK (a) (Etges et al., 2016), or an observational study in Spain (b) (Oreja‐Guevara, 2015). (a) Product registry (Germany, Switzerland, and the UK; n = 387). (b) Observational study data, Spain (n = 77)